E
Effie W. Petersdorf
Researcher at Fred Hutchinson Cancer Research Center
Publications - 242
Citations - 20326
Effie W. Petersdorf is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 67, co-authored 234 publications receiving 18917 citations. Previous affiliations of Effie W. Petersdorf include University of Oxford & National Taiwan University.
Papers
More filters
Journal ArticleDOI
Trends in transplantation of hematopoietic stem cells from unrelated donors.
TL;DR: Improved methods for transplantation may provide the opportunity to further decrease treatment-related toxicity and improve survival and the selection of compatible donors has become more effective.
Journal ArticleDOI
Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes.
Effie W. Petersdorf,Robert L. Griffith,Henry A. Erlich,Eric Mickelson,Anajane G. Smith,B. Nisperos,Paul J. Martin,Paul J. Martin,John A. Hansen,John A. Hansen +9 more
TL;DR: The results of this study suggest that the DRw52 family haplotypes is derived from a relatively restricted number of ancestral sequences, with diversity among DRB1 alleles within this family arising through gene conversion or recombination events.
Journal ArticleDOI
The HLA Complex in Biology and Medicine: A Resource Book
TL;DR: The importance of HLA in transplantation is highlighted in the final group of chapters, starting with an elegant essay on HLA allorecognition in the transplant model, and ending with practical issues confronted by unrelated donor registries that support blood and marrow transplantation.
Journal ArticleDOI
Unrelated and HLA-Nonidentical Related Donor Marrow Transplantation forThalassemia and Leukemia: A Combined Report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registrya
Keith M. Sullivan,Claudio Anasetti,Claudio Anasetti,Mary M. Horowitz,Mary M. Horowitz,Philip A. Rowlings,Philip A. Rowlings,Effie W. Petersdorf,Effie W. Petersdorf,Paul J. Martin,Paul J. Martin,Reginald A. Clift,Mark C. Walters,Mark C. Walters,Ted Gooley,Jorge Sierra,Jeanne E. Anderson,Jeanne E. Anderson,Jeanie Bjerke,Muriel F. Siadak,Mary E.D. Flowers,Richard A. Nash,Richard A. Nash,Jean E. Sanders,Jean E. Sanders,F R Appelbaum,F R Appelbaum,R Storb,R Storb,J.A. Hansen,J.A. Hansen +30 more
TL;DR: Using the paradigm of CML, it is likely that access to curative therapy of thalassemia will improve with optimal HLA typing and donor selection early in the course of disease.
Journal ArticleDOI
Center for International Blood and Marrow Transplant Research Chronic Graft-versus-Host Disease Risk Score Predicts Mortality in an Independent Validation Cohort
Mukta Arora,Michael T. Hemmer,Kwang Woo Ahn,John P. Klein,Corey Cutler,Alvaro Urbano-Ispizua,Daniel R. Couriel,Amin M. Alousi,Robert Peter Gale,Yoshihiro Inamoto,Daniel J. Weisdorf,Peigang Li,Joseph H. Antin,Brian J. Bolwell,Michael Boyiadzis,Jean-Yves Cahn,Mitchell S. Cairo,Luis Isola,David A. Jacobsohn,Madan Jagasia,Thomas R. Klumpp,Effie W. Petersdorf,Stella Santarone,Harry C. Schouten,John R. Wingard,Stephen R. Spellman,Steven Z. Pavletic,Stephanie J. Lee,Mary M. Horowitz,Mary E.D. Flowers +29 more
TL;DR: The study validates the prognostic value of the CIBMTR CGVHD RGs for overall survival and NRM in a contemporary transplantation population and can be used to predict major outcomes, tailor treatment planning, and enroll patients in clinical trials.